On March 23 Julia Trakhtenberg, IPHARMA Medical Director, reported in VIII Scientific-Practical conference on the "Actual tasks of drugs safety evaluation" with the report "Data collection and safety evaluation planning. Clinical trials in diabetology".
In conference the questions of regulation, drugs safety evaluation in preclinical and clinical trials and specialty in toxicology was discussed.
Julia Trakhtenberg told about specifics of population in clinical trials of diabetes mellitus type I on screening and conducting stages, premature termination and specifics of medical monitoring. She also given the benefit of experience of planning and safety data collection.